|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001899,
umls-concept:C0008976,
umls-concept:C0022341,
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0229671,
umls-concept:C0301630,
umls-concept:C0302583,
umls-concept:C0441889,
umls-concept:C0524910,
umls-concept:C0750502,
umls-concept:C2587213
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-7-5
|
|
pubmed:abstractText |
Increasing evidence indicates that iron cytotoxicity plays an important role in the pathogenesis of chronic hepatitis C (CHC). However, the biochemical effects of iron reduction therapy on CHC remain to be confirmed in a controlled study. This study aimed to test whether iron removal by repeated phlebotomy improves serum alanine aminotransferase (ALT) levels in patients with CHC.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0944-1174
|
|
pubmed:author |
pubmed-author:HayashiHisaoH,
pubmed-author:IinoShiroS,
pubmed-author:IkomaJiroJ,
pubmed-author:KaitoMasahikoM,
pubmed-author:KajiwaraEijiE,
pubmed-author:KakumuShinichiS,
pubmed-author:KatoJunjiJ,
pubmed-author:KawamuraKinyaK,
pubmed-author:KimuraFumiakiF,
pubmed-author:KobayashiYoshimasaY,
pubmed-author:KohgoYutakaY,
pubmed-author:NiitsuYoshiroY,
pubmed-author:OgataKeiK,
pubmed-author:OkanoueTakeshiT,
pubmed-author:SaitoHiroyukiH,
pubmed-author:SataMichioM,
pubmed-author:SumidaYoshioY,
pubmed-author:WakusawaShinyaS,
pubmed-author:YanoMotoyoshiM,
pubmed-author:YoshiokaKentaroK,
pubmed-author:YotsuyanagiHiroshiH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
570-4
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15235875-Adult,
pubmed-meshheading:15235875-Alanine Transaminase,
pubmed-meshheading:15235875-Cholagogues and Choleretics,
pubmed-meshheading:15235875-Female,
pubmed-meshheading:15235875-Hepatitis C, Chronic,
pubmed-meshheading:15235875-Humans,
pubmed-meshheading:15235875-Iron Overload,
pubmed-meshheading:15235875-Male,
pubmed-meshheading:15235875-Middle Aged,
pubmed-meshheading:15235875-Phlebotomy,
pubmed-meshheading:15235875-Prospective Studies,
pubmed-meshheading:15235875-Ursodeoxycholic Acid
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
|
|
pubmed:affiliation |
Third Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, 466-8550, Nagoya, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
